Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three cases

Tumori

Volumn 89, Issue 3, 2003, Pages 311-313

  Libra, Massimo ^a   Sorio, Roberto ^a   Buonadonna, Angela ^a   Berretta, Massimiliano ^a   Stefanovski, Peter ^a   Toffoli, Giuseppe ^a   Mazzaglia, Giovanna ^a   Cordani, Nicoletta ^b   Stivala, Franca ^b   Boiocchi, Mauro ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NONE

Author keywords

Carboplatin; Hypersensitivity reactions; Ovarian cancer

Indexed keywords

CARBOPLATIN; CHLORPHENIRAMINE; CISPLATIN; DEXAMETHASONE; HYDROCORTISONE; OXYGEN;

ADULT; ARTICLE; CASE REPORT; DRUG HYPERSENSITIVITY; DYSPEPSIA; EXTRASYSTOLE; FEMALE; HUMAN; HYPERTENSIVE CRISIS; OVARY CARCINOMA; OXYGEN THERAPY; RASH; SIDE EFFECT; VALIDATION PROCESS; VOMITING;

EID: 0042428915     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160308900315     Document Type: Article

References (13)

1. Lokich J, Anderson N: Carboplatin versus cisplatin in solid tumors: an analysis of the literature. Ann Oncol, 9: 13-21, 1998.
2. Gore ME, Fryatt I, Wiltshaw E, Dawson T: Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds. Gynecol Oncol, 36: 207-211, 1990.
3. Markman M, Kennedy A, Webster K, Elson P, Peterson, Kulp B, Belinson J: Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol, 17: 1141-1145, 1999.
4. Rose PG, Fusco N, Fluellen L, Rodriguez M: Carboplatin hypersensitivity reactions in patients with ovarian and peritoneal carcinoma. Int J Gynecol Cancer. 8: 365-368, 1998.
5. Weidmann B, Mulleneisen N, Bojko P, Niederle N: Hypersensitivity reactions to carboplatin: report of two patients, review of the literature, and discussion of diagnostic procedures and management. Cancer, 73: 2218-2222, 1994.
6. Chang SM, Fryberger S, Crouse V, Tilford D, Prados MD: Carboplatin hypersensitivity in children. A report of five patients with brain tumors. Cancer, 75: 1171-1175, 1995.
7. Friedman HS, Krischer JP, Burger P, Oakes WJ, Hockenberger B, Weiner MD, Falletta JM, Norris D, Ragab AH, Mahoney DH Jr, Whitehead MV, Kun LE: Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study. J Clin Oncol. 10: 249-246, 1992.
8. Planner RS, Weerasiri T, Timmins D, Grant P: Hypersensitivity reactions to carboplatin. J Natl Cancer Inst, 83: 1763-1764, 1991.
9. Bacha DM, Caparros-Sison B, Allen JA, Walker R, Tan CT: Phase I study of carboplatin (CBDCA) in children with cancer. Cancer Treat Rep, 70: 865-869, 1986.
10. Tonkin KS, Rubin P, Levin L: Carboplatin hypersensitivity: case reports and review of the literature. Eur J Cancer, 29A: 1356-1357, 1993.
11. Saunders MP, Denton CP, O'Brien ME, Blake P, Gore M, Wiltshaw E: Hypersensitivity reactions to cisplatin and carboplatin-a report on six cases. Ann Oncol, 3: 574-576, 1992.
12. Gutierrez M, Pautier P, Lhomme C: Replacement of carboplatin by oxaliplatin may be one solution for patients treated for ovarian carcinoma who are hypersensitive to carboplatin. J Clin Oncol, 20: 353, 2002.
13. Shukunami K, Kurokawa T, Kubo M, Kaneshima M, Kamitani N, Kotsuji F: Hypersensitivity reaction to carboplatin during treatment for ovarian cancer: successful resolution by replacement with cisplatin. Tumori, 85: 297-298, 1999.